BiVictriX Therapeutics Plc (BVX.L)

GBp 10.0

(17.65%)

Annual Income Statements

(In GBP)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 165 Thousand 151 Thousand 46 Thousand 1000.00 - -
Gross Profit -165 Thousand -151 Thousand -46 Thousand -1000.00 - -
Operating Expenses 2.86 Million 2.97 Million 1.5 Million 521 Thousand 526 Thousand 480 Thousand
Selling, General and Administrative Expenses 978 Thousand 738 Thousand 567 Thousand 215 Thousand - -
Research and Development Expenses 1.88 Million 2.11 Million 711 Thousand 305 Thousand - -
Other Expenses - 127 Thousand 224 Thousand 521 Thousand 526 Thousand 480 Thousand
Cost and Expenses 3.02 Million 2.97 Million 1.5 Million 521 Thousand 526 Thousand 480 Thousand
Operating Income -3.02 Million -2.97 Million -1.89 Million -490 Thousand -526 Thousand -480 Thousand
Interest Expense - - 641 Thousand 19 Thousand - -
Income Tax Expense -458 Thousand -474 Thousand -193 Thousand -84 Thousand -117 Thousand -102 Thousand
Earnings before Tax -3 Million -2.97 Million -2.53 Million -509 Thousand -526 Thousand -480 Thousand
Net Income -2.54 Million -2.49 Million -2.33 Million -425 Thousand -409 Thousand -378 Thousand
Earnings Per Share Basic -0.04 -0.04 -0.04 -0.02 -0.01 -0.01
Earnings Per Share Diluted -0.04 -0.04 -0.04 -0.02 -0.01 -0.01
Weighted Average Shares Outstanding 72.64 Million 66.11 Million 66.11 Million 23.96 Million 66.11 Million 66.11 Million
Weighted Average Shares Outstanding (Diluted) 72.64 Million 66.11 Million 66.11 Million 23.96 Million 66.11 Million 66.11 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -2.86 Million -2.82 Million -1.45 Million -520 Thousand -526 Thousand -480 Thousand
Earnings Before Tax Margin - - - - - -

Income Statement Charts